Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1151-1160 of 3548 for cancer

Edit search filters
  1. Study of the NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung

    Rochester, MN

  2. A Study Using Gallium-68 PSMA-11 and C-11 Choline PET Imaging to Detect Metastatic Prostate Cancer in Patients

    Rochester, MN

  3. A Study to Evaluate Effectiveness and Safety of MBG453 in Combination with Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS), or Chronic Myelomonocytic Leukemia-2 (CMML-2)

    Jacksonville, FL

  4. A Study To Assess Adverse Events Of Intravenously (IV) Infused ABBV-383 In Adult Participants With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. An Optimized Ultrasound Twinkling Marker For The Imaging Of Lymph Nodes In Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial

    Rochester, MN

  6. TransCon (TC) TLR7/​8 Agonist, TC IL-2 Β/​γ, Pembrolizumab Prior To Surgery For Advanced Head And Neck Squamous Cell Carcinoma (BelieveIT-201)

    Rochester, MN

  7. BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

    Rochester, MN

  8. Short-course Radiation Therapy for Hepatocellular Carcinoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer

    Rochester, MN

  10. Evaluation of Safety and Efficacy of Allo GDA-201 NK Cells in Patients With Relapsed/Refractory B Cell NHL

    Jacksonville, FL

.

Mayo Clinic Footer